Publication | Closed Access
513 Darifenacin, an M3 selective receptor antagonist for the treatment of overactive bladder, does not affect cognitive function in elderly volunteers
11
Citations
0
References
2004
Year
Molecular PharmacologyUrologyVoiding DysfunctionGeriatricsMedicineGeriatric UrologyNeuropharmacologyCognitive FunctionPharmacotherapyElderly VolunteersPharmacologyDrug DiscoveryOveractive Bladder
No additional data available for this publication yet. Check back later!